Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
FDA Approves Johnson & Johnson s Single-Shot Vaccine
FDA Approves Johnson & Johnson s Single-Shot Vaccine
The emergency-use authorization comes days after the FDA released a review finding the single-dose vaccine to be safe and effective
Ryan Bort, provided by
FacebookTwitterEmail
NEW: Johnson & Johnson single shot vaccine just approved by FDA for 18 and older.
More from Rolling Stone
The authorization comes days after the FDA released a report finding the vaccine to be safe and effective. Vaccines by Moderna and Pfizer, both of which require two shots administered weeks apart, have already been approved for use.
Original story below.
It looks like we’re about to have a new vaccine, and it only requires one dose.
It came just hours after Novavax announced its coronavirus vaccine – of which the UK has ordered 60 million doses. It is 89 percent effective at stopping infection and 86 percent effective against the new Kent variant of the virus.
More than 43,000 people from eight countries and three regions took part in trials of the single-shot vaccine from Johnson & Johnson, which was developed by its pharmaceutical arm Janssen.
Deliveries of the Janssen jab could begin arriving in Britain in the second half of the year, provided it receives the green light from regulators.
Dr Paul Stoffels, Johnson & Johnson’s chief scientific officer, said the jab could significantly ease the burden on health services across the world, particularly as only one dose